OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Soluble TREM2: Innocent bystander or active player in neurological diseases?
Fabia Filipello, Claire Goldsbury, Shih Feng You, et al.
Neurobiology of Disease (2022) Vol. 165, pp. 105630-105630
Open Access | Times Cited: 84
Fabia Filipello, Claire Goldsbury, Shih Feng You, et al.
Neurobiology of Disease (2022) Vol. 165, pp. 105630-105630
Open Access | Times Cited: 84
Showing 1-25 of 84 citing articles:
TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease
Yueran Li, Huifang Xu, Huifang Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115218-115218
Open Access | Times Cited: 47
Yueran Li, Huifang Xu, Huifang Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115218-115218
Open Access | Times Cited: 47
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer’s disease
Lihua Wang, Niko-Petteri Nykänen, Daniel Western, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 22
Lihua Wang, Niko-Petteri Nykänen, Daniel Western, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 22
Neuraminidase 1 regulates neuropathogenesis by governing the cellular state of microglia via modulation of Trem2 sialylation
Leigh Ellen Fremuth, Huimin Hu, Diantha van de Vlekkert, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115204-115204
Open Access | Times Cited: 2
Leigh Ellen Fremuth, Huimin Hu, Diantha van de Vlekkert, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115204-115204
Open Access | Times Cited: 2
Stimulation of TREM2 with agonistic antibodies—an emerging therapeutic option for Alzheimer's disease
Kai Schlepckow, Estrella Morenas‐Rodríguez, Soyon Hong, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 11, pp. 1048-1060
Open Access | Times Cited: 37
Kai Schlepckow, Estrella Morenas‐Rodríguez, Soyon Hong, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 11, pp. 1048-1060
Open Access | Times Cited: 37
Trem2 expression in microglia is required to maintain normal neuronal bioenergetics during development
Erica Tagliatti, Genni Desiato, Sara Mancinelli, et al.
Immunity (2023) Vol. 57, Iss. 1, pp. 86-105.e9
Open Access | Times Cited: 37
Erica Tagliatti, Genni Desiato, Sara Mancinelli, et al.
Immunity (2023) Vol. 57, Iss. 1, pp. 86-105.e9
Open Access | Times Cited: 37
Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation
Fabia Filipello, Shih‐Feng You, Farzaneh S. Mirfakhar, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 6, pp. 749-772
Open Access | Times Cited: 32
Fabia Filipello, Shih‐Feng You, Farzaneh S. Mirfakhar, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 6, pp. 749-772
Open Access | Times Cited: 32
TREM2: A new player in the tumor microenvironment
Martina Molgora, Yizhou Liu, Marco Colonna, et al.
Seminars in Immunology (2023) Vol. 67, pp. 101739-101739
Open Access | Times Cited: 29
Martina Molgora, Yizhou Liu, Marco Colonna, et al.
Seminars in Immunology (2023) Vol. 67, pp. 101739-101739
Open Access | Times Cited: 29
Fluid biomarkers in multiple sclerosis: from current to future applications
Massimiliano Di Filippo, Lorenzo Gaetani, Diego Centonze, et al.
The Lancet Regional Health - Europe (2024) Vol. 44, pp. 101009-101009
Open Access | Times Cited: 11
Massimiliano Di Filippo, Lorenzo Gaetani, Diego Centonze, et al.
The Lancet Regional Health - Europe (2024) Vol. 44, pp. 101009-101009
Open Access | Times Cited: 11
The therapeutic potential of TREM2 in cancer
Elysa M. Wolf, Barbara Fingleton, Alyssa H. Hasty
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 31
Elysa M. Wolf, Barbara Fingleton, Alyssa H. Hasty
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 31
The role of triggering receptor expressed on myeloid cells-1 (TREM-1) in central nervous system diseases
Chunyan Zhang, Xugang Kan, Baole Zhang, et al.
Molecular Brain (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Chunyan Zhang, Xugang Kan, Baole Zhang, et al.
Molecular Brain (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 29
TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation
Miguel Moutinho, Israel Coronel, Andy P. Tsai, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Miguel Moutinho, Israel Coronel, Andy P. Tsai, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Serum Biomarkers of a Pro-Neuroinflammatory State May Define the Pre-Operative Risk for Postoperative Delirium in Spine Surgery
Johanna Ruhnau, Jonas Müller, Stephan Nowak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10335-10335
Open Access | Times Cited: 20
Johanna Ruhnau, Jonas Müller, Stephan Nowak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10335-10335
Open Access | Times Cited: 20
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
Yanaika S. Hok‐A‐Hin, Marta del Campo, Walter Boiten, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 17
Yanaika S. Hok‐A‐Hin, Marta del Campo, Walter Boiten, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 17
TREM2 is down-regulated by HSV1 in microglia and involved in antiviral defense in the brain
Stefanie Fruhwürth, Line S. Reinert, C Oberg, et al.
Science Advances (2023) Vol. 9, Iss. 33
Open Access | Times Cited: 17
Stefanie Fruhwürth, Line S. Reinert, C Oberg, et al.
Science Advances (2023) Vol. 9, Iss. 33
Open Access | Times Cited: 17
Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders
Chuanbo Qin, Man Chen, Minghao Dong, et al.
Brain (2023) Vol. 147, Iss. 1, pp. 163-176
Closed Access | Times Cited: 16
Chuanbo Qin, Man Chen, Minghao Dong, et al.
Brain (2023) Vol. 147, Iss. 1, pp. 163-176
Closed Access | Times Cited: 16
APOE and immunity: Research highlights
Courtney M. Kloske, Christopher J. Barnum, André F. Batista, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 6, pp. 2677-2696
Open Access | Times Cited: 15
Courtney M. Kloske, Christopher J. Barnum, André F. Batista, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 6, pp. 2677-2696
Open Access | Times Cited: 15
Function and mechanism of TREM2 in bacterial infection
Zehua Wu, Shiyue Yang, Xiangming Fang, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 1, pp. e1011895-e1011895
Open Access | Times Cited: 5
Zehua Wu, Shiyue Yang, Xiangming Fang, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 1, pp. e1011895-e1011895
Open Access | Times Cited: 5
TREM2 variants that cause early dementia and increase Alzheimer’s disease risk affect gene splicing
Kostantin Kiianitsa, Maria E Lukes, Brian Hayes, et al.
Brain (2024) Vol. 147, Iss. 7, pp. 2368-2383
Closed Access | Times Cited: 4
Kostantin Kiianitsa, Maria E Lukes, Brian Hayes, et al.
Brain (2024) Vol. 147, Iss. 7, pp. 2368-2383
Closed Access | Times Cited: 4
Role of TREM2 in immune and neurological diseases: Structure, function, and implications
Peng Yin, Zhaoliang Su, Xiaozheng Shu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113286-113286
Closed Access | Times Cited: 4
Peng Yin, Zhaoliang Su, Xiaozheng Shu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113286-113286
Closed Access | Times Cited: 4
Cerebrospinal Fluid Biomarkers as Predictors of Multiple Sclerosis Severity
Miguel Tolentino, Francesca Pace, Dana C. Perantie, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 94, pp. 106268-106268
Closed Access
Miguel Tolentino, Francesca Pace, Dana C. Perantie, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 94, pp. 106268-106268
Closed Access
HEBE: A novel chimeric chronokine for ameliorating memory deficits in Alzheimer’s disease
Jon Esandi, Pedro Renault, Maria Dolores Capilla-López, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117815-117815
Closed Access
Jon Esandi, Pedro Renault, Maria Dolores Capilla-López, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117815-117815
Closed Access
Retrotrans-genomics identifies aberrant THE1B endogenous retrovirus fusion transcripts in the pathogenesis of sarcoidosis
Shunsuke Funaguma, Aritoshi Iida, Yoshihiko Saito, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Shunsuke Funaguma, Aritoshi Iida, Yoshihiko Saito, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Osteopontin in Alzheimer's Disease: A Double‐Edged Sword in Neurodegeneration and Neuroprotection—A Systematic Review
Zahra Azizan, Maryam Bazrgar, Narges Bazgir, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 2
Open Access
Zahra Azizan, Maryam Bazrgar, Narges Bazgir, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 2
Open Access
The Role of TREM2 in Myelin Sheath Dynamics: A Comprehensive Perspective from Physiology to Pathology
Xinwei Que, Tongtong Zhang, X Y Liu, et al.
Progress in Neurobiology (2025) Vol. 247, pp. 102732-102732
Closed Access
Xinwei Que, Tongtong Zhang, X Y Liu, et al.
Progress in Neurobiology (2025) Vol. 247, pp. 102732-102732
Closed Access
The various roles of TREM2 in cardiovascular disease
Shuai Wang, Chenghui Cao, Daoquan Peng
Frontiers in Immunology (2025) Vol. 16
Open Access
Shuai Wang, Chenghui Cao, Daoquan Peng
Frontiers in Immunology (2025) Vol. 16
Open Access
